Recent studies investigating the molecular pathogenesis of HCC have revealed that blocking MEK/ERK signaling in HCC cells results in multiple anticancer effects such as decreased HCC cell proliferation, growth, and increased apoptosis [51]. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.